<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02385968</url>
  </required_header>
  <id_info>
    <org_study_id>S-20140085</org_study_id>
    <nct_id>NCT02385968</nct_id>
  </id_info>
  <brief_title>Detection of Bacteria in Herniated Nucleus Material in Lumbar Disc Herniations by Culture and PCR</brief_title>
  <official_title>Detection of Bacteria in Herniated Nucleus Material in Lumbar Disc Herniations by Culture and PCR</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sygehus Lillebaelt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vejle Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sygehus Lillebaelt</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to investigate if herniated nucleus material in lumbar disc herniations is
      infected with bacteria, and if so, to determine their prevalence (control group), and to
      determine if patients with pre-existing Modic changes type 1 have a higher incidence of
      bacterial growth in relevant lumbar disc samples than patients without Modic changes.

      A cohort of 15 patients with pre-existing Modic and 15 without-undergoing primary surgery
      will be examined.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The nucleus material will be evacuated and divided into 5 biopsies, each with a new set of
      sterile instruments and placed in separate sterile glass vials with one drop of sterile
      saline to prevent drying of biopsy.

      The primary outcome, i.e., bacterial growth on a per-patient basis. Bacterial growth shall be
      detected in minimum 3 out of 5 biopsies for the patient to be scored as positive for
      bacteria.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Not possible to recruit
  </why_stopped>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bacterial growth on a per-patient basis</measure>
    <time_frame>at time of surgery</time_frame>
  </primary_outcome>
  <enrollment type="Actual">5</enrollment>
  <condition>Lumbar Disc Herniations</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Biopsies of Nucleus
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with MRI-confirmed lumbar disc herniation. Lumbar disc herniation. Age between 18
        and 65 years. No prior spine surgery. No diagnosed dementia.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  MRI-confirmed lumbar disc herniation.

          -  Age between 18 and 65 years.

          -  No prior spine surgery.

          -  No diagnosed dementia.

        Exclusion Criteria:

          -  Antibiotic treatment within the previous two weeks.

          -  History of alcohol abuse, illicit drug use or drug abuse, or significant mental
             illness

          -  Known immune deficiency state (e.g., positive for human immunodeficiency virus) or in
             treatment with immunosuppressive drugs including high dose steroids or cyclosporine.

          -  Concurrent infections (infections of skin, urinary tract infection, other skin
             diseases, e.g. Acne vulgaris).

          -  Previous epidural instrumentation.

          -  Uncontrolled, unstable or recently diagnosed autoimmune disease, including but not
             limited to systemic lupus erythematosus, inflammatory bowel disease, sarcoidosis,
             rheumatoid arthritis, or psoriasis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen H. Hansen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sygehus Lillebaelt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Middelfart Spinesurgery research department</name>
      <address>
        <city>Middelfart</city>
        <state>Region Of Southern Denmark</state>
        <zip>5500</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2015</study_first_submitted>
  <study_first_submitted_qc>March 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2015</study_first_posted>
  <last_update_submitted>December 4, 2017</last_update_submitted>
  <last_update_submitted_qc>December 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sygehus Lillebaelt</investigator_affiliation>
    <investigator_full_name>Karen Hoejmark Hansen</investigator_full_name>
    <investigator_title>Research nurse</investigator_title>
  </responsible_party>
  <keyword>Modic</keyword>
  <keyword>Microbiology</keyword>
  <keyword>Immunology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

